Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects
Clinical trial NCT04032535 · COMPLETED
Trial details
- NCT number
- NCT04032535
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2022-12-05
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.